World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
158
Citations
91066
World Ranking
90
National Ranking
58

Medicine

D-Index
158
Citations
91241
World Ranking
860
National Ranking
491

Joost J. Oppenheim publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Joost J. Oppenheim sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 579 publications — 93rd percentile

93% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Joost J. Oppenheim D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Joost J. Oppenheim sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 158 D-Index — 98th percentile

98% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Joost J. Oppenheim was affiliated with the National Institutes of Health in the United States. Their research primarily focused on immunology, molecular biology, and medicine, with a significant emphasis on subfields such as immunology, oncology, molecular biology, neurology, and cellular and molecular neuroscience.

The main scientific topics covered in their work included:

  • Immunotherapy and Immune Responses
  • Cancer Immunotherapy and Biomarkers
  • Immune Cell Function and Interaction
  • RNA Interference and Gene Delivery
  • Chemokine receptors and signaling
  • T-cell and B-cell Immunology
  • Cancer Research and Treatments

Their most frequent co-authors were:

  • De Yang
  • Md Masud Alam
  • Kouji Matsushima
  • Xiaoqing Li
  • Anna Trivett

Oppenheim published mainly in the following venues:

  • The Journal of Immunology
  • IUPHAR/BPS Guide to Pharmacology CITE
  • Cytokine
  • Cell Reports
  • International Immunopharmacology

Some of their recent research papers included:

  • "Interleukin-8: An evolving chemokine", 2022, Cytokine
  • "Alpha synuclein, the culprit in Parkinson disease, is required for normal immune function", 2022, Cell Reports
  • "A TNFR2 antibody by countering immunosuppression cooperates with HMGN1 and R848 immune stimulants to inhibit murine colon cancer", 2021, International Immunopharmacology
  • "Cytidine acetylation yields a hypoinflammatory synthetic messenger RNA", 2021, Cell chemical biology
  • "Combining an Alarmin HMGN1 Peptide with PD-L1 Blockade Results in Robust Antitumor Effects with a Concomitant Increase of Stem-Like/Progenitor Exhausted CD8+ T Cells", 2021, Cancer Immunology Research

Best Publications

  • β-Defensins: Linking Innate and Adaptive Immunity Through Dendritic and T Cell CCR6

    D. Yang;O. Chertov;S. N. Bykovskaia;Q. Chen

  • International Union of Pharmacology. XXII. Nomenclature for Chemokine Receptors

    Philip M. Murphy;Marco Baggiolini;Israel F. Charo;Caroline A. Hébert

  • Properties of the Novel Proinflammatory Supergene "Intercrine" Cytokine Family

    J. J. Oppenheim;C. O. C. Zachariae;N. Mukaida;K. Matsushima

  • Ll-37, the Neutrophil Granule–And Epithelial Cell–Derived Cathelicidin, Utilizes Formyl Peptide Receptor–Like 1 (Fprl1) as a Receptor to Chemoattract Human Peripheral Blood Neutrophils, Monocytes, and T Cells

    De Yang;Qian Chen;Albert P. Schmidt;G. Mark Anderson

  • There is more than one interleukin 1.

    Joost J. Oppenheim;Elizabeth J. Kovacs;Kouji Matsushima;Scott K. Durum

  • Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor.

    Kouji Matsushima;Kazuhiro Morishita;Teizo Yoshimura;Sukadev Lavu

  • Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines

    Teizo Yoshimura;Kouji Matsushima;Shuji Tanaka;Elizabeth A. Robinson

  • The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes.

    Christian Grønhøj Larsen;Arthur O. Anderson;Ettore Appella;Joost J. Oppenheim

  • Toll-Like Receptor 4-Dependent Activation of Dendritic Cells by β-Defensin 2

    Arya Biragyn;Pier Adelchi Ruffini;Cynthia A. Leifer;Elena Klyushnenkova

  • Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line

    K Matsushima;C G Larsen;G C DuBois;J J Oppenheim

  • Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression.

    Rosalba Salcedo;Maria Lourdes Ponce;Howard A. Young;Ken Wasserman

  • Alarmins: chemotactic activators of immune responses.

    Joost J Oppenheim;De Yang

  • Mammalian defensins in immunity: more than just microbicidal.

    De Yang;Arya Biragyn;Larry W Kwak;Joost J Oppenheim

  • Recombinant Human Interferon-inducible Protein 10 Is a Chemoattractant for Human Monocytes and T Lymphocytes and Promotes T Cell Adhesion to Endothelial Cells

    Dennis D. Taub;Andrew R. Lloyd;Kevin Conlon;Ji Ming Wang

  • Preferential migration of activated CD4+ and CD8+ T cells in response to MIP-1 alpha and MIP-1 beta

    Dennis D. Taub;Kevin Conlon;Andrew R. Lloyd;Joost J. Oppenheim

  • Interleukin 8 and MCAF: novel inflammatory cytokines inducible by IL 1 and TNF.

    Kouji Matsushima;Joost J. Oppenheim

  • Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin 1 (IL 1).

    Teizo Yoshimura;Kouji Matsushima;Joost J Oppenheim;Edward J Leonard

  • Vascular Endothelial Growth Factor and Basic Fibroblast Growth Factor Induce Expression of CXCR4 on Human Endothelial Cells: In Vivo Neovascularization Induced by Stromal-Derived Factor-1α

    Rosalba Salcedo;Ken Wasserman;Howard A. Young;Michael C. Grimm

  • The functional relationship of the interleukins.

    Kendall A. Smith;Lawrence B. Lachman;Joost J. Oppenheim;Margaret F. Favata

  • Interleukin 1: an immunological perspective.

    Scott K. Durum;John A. Schmidt;Joost J. Oppenheim

  • Multiple Roles of Antimicrobial Defensins, Cathelicidins, and Eosinophil-Derived Neurotoxin in Host Defense*

    De Yang;Arya Biragyn;David M. Hoover;Jacek Lubkowski

Frequent Co-Authors

De Yang
De Yang National Cancer Research Institute, UK
Xin Chen
Xin Chen University of Macau
Kouji Matsushima
Kouji Matsushima Tokyo University of Science
O. M. Zack Howard
O. M. Zack Howard National Institutes of Health
Ji Ming Wang
Ji Ming Wang National Institutes of Health
David L. Rosenstreich
David L. Rosenstreich National Institutes of Health
Andrew R. Lloyd
Andrew R. Lloyd University of New South Wales
Dennis D. Taub
Dennis D. Taub George Washington University
Dan L. Longo
Dan L. Longo Harvard University
Stephan E. Mergenhagen
Stephan E. Mergenhagen National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in applying their Immunology background towards healthcare, pursuing advanced nursing roles can be a valuable pathway. Programs like the top psychiatric mental health nurse practitioner programs online offer flexible learning combined with high-quality clinical placements, making it easier to balance education and practical experience.

Cost is often a crucial factor when choosing the right program. Exploring the cheapest pmhnp certificate programs can help prospective students find accredited routes that fit their budget without compromising education standards.

Career advancement in nursing also includes understanding salary prospects. The dnp salary by state resource provides valuable insights into how earnings can vary geographically, helping graduates make informed decisions about where to work.

Additionally, nurses considering shifts in specialization can learn practical steps such as how to transition from FNP to acute care NP, opening up new clinical roles and opportunities. This transition is well detailed in the fnp to acute care np guide, which outlines the coursework and certifications needed to succeed.

Best Scientists Citing Joost J. Oppenheim

Recently Published Articles